Seneca Harberger, a medical student at Temple University School of Medicine, has been named a 2014 Pisacano Scholar by the Board of Directors of the Pisacano Leadership Foundation, Inc., of the American Board of Family Medicine.
Temple University Hospital is the first hospital in the Philadelphia region to offer an innovative, minimally-invasive technology that improves long-term outcomes for patients with complex anatomies undergoing endovascular repair of abdominal aortic aneurysms (EVAR). The Aorfix™ Endovascular Stent Graft utilizes a flexible, helical and circular design to conform to the natural contours of human anatomy, including highly-angled aortic necks.
Temple University Hospital has performed the Philadelphia region's first surgery using the new da Vinci® Xi™ Surgical System. Surgeons at Temple successfully performed a minimally invasive robotic mitral valve repair using the da Vinci Xi on July 22. The new technology has broader capabilities than prior generations of surgical robots.
Asking patients if a suspicious skin lesion is painful or itchy may help doctors decide whether the spot is likely to be cancerous, according to a new study headed by Gil Yosipovitch, MD, Chairman of the Department of Dermatology at Temple University School of Medicine.
Temple University Hospital is the first hospital in Pennsylvania to offer an innovative procedure that improves long-term outcomes for patients undergoing endovascular repair of thoracic aortic aneurysms (TEVAR). Using a spiral-shaped screw which is delivered from inside the aorta, the Heli-FX™ Thoracic EndoAnchor System uses a special anchor technology to secure stents to the wall of the aorta, preventing migration of the stent and providing a leak-resistant seal between the stent and the aorta.
Cherie P. Erkmen, MD, has been appointed Director of the Lung Cancer Screening Program at Temple University Hospital, and Associate Professor of Surgery at Temple University School of Medicine, effective July 21, 2014.
Patients who have a clot in their legs and are considering whether to be treated with traditional blood-thinning medication or undergo a minimally-invasive catheter-based clot removal procedure should feel comfortable that there is no difference in death rates between the two treatments, although there are more bleeding risks with the catheter procedure, according to a study by Temple University School of Medicine researchers. The study involved a review of more than 90,000 cases nationwide.
“Cents and Sensibilities” was the theme of the 22nd annual Temple University School of Medicine (TUSM) Faculty Development Day – sponsored by the school’s Committee on the Status of Women Faculty.
“And we didn’t pick the theme just because I’m a huge Jane Austen fan,” joked Committee Chair Mary Kraemer, MD, Associate Professor of Medicine and an undergraduate Philosophy/English major. “We’re here today to celebrate women and discuss women’s leadership roles both at Temple and throughout the medical field.”